Skip to main content
. 2021 Feb 3;9(2):E253–E257. doi: 10.1055/a-1324-2892

Table 3. Technical and quality results.

n = 37
Technical success rate 92 % (34 patients)
Median number of inserted markers (per patient) 3 (0–4)
Adverse events (%) 8 %
Fever 2.7 %
Mild acute pancreatitis 2.7 %
Biliary stent migration 2.7 %
n = 34
SBRT delivered (%) 97.1 %
Markers migration rate (%) 5.9 % (2 patients)
n = 32
Markers inside the tumor or < 1 cm
  • 1 (1)

12.5 %
  • 2 (2)

31.3 %
  •  ≥ 3 (3)

56.2 %
Markers in the extremity of the tumor
  • 0 (0)

25 %
  • 1 (1)

68.8 %
  •  ≥ 2 (2)

12.5 %
Markers in different planes
  • Yes (2)

56.3 %
  • No (0)

43.7 %
Distance from the biliary stent > 1 mm
  • No (0)

15.6 %
  • Yes (2)

84.4 %
Overlap FEV
  • Yes (0)

71.9 %
  • No (3)

28.1 %

(n) = Points attributed accordingly to the quality score.